Outcome | Baseline | Month 6 | |||||
---|---|---|---|---|---|---|---|
Control (n = 20) | Intervention (n = 20) | p* | Control (n = 19) | Intervention (n = 20) | p* | Beta (SE); p | |
Sharing of CC screening result with others | 1.47 (0.62) | 1.62 (0.39) | 0.37 | 1.58 (0.48) | 1.93 (0.21) | 0.006 | 0.31 (0.11); 0.008 |
CC knowledge | 8.55 (2.80) | 10.05 (3.36) | 0.13 | 8.50 (2.37) | 15.70 (0.66) | < 0.001 | 6.90 (0.54); <0.001 |
CC internalized stigma | 1.21 (0.35) | 1.07 (0.16) | 0.12 | 1.08 (0.29) | 1.00 (0.00) | 0.13 | -0.04 (0.05); 0.42 |
CC risk manangement self-efficacy | 8.70 (1.40) | 8.85 (1.28) | 0.73 | 7.40 (2.16) | 10.00 (0.00) | < 0.001 | 2.56 (0.47); <0.001 |
CC prevention advocacy self-efficacy | 9.75 (0.46) | 9.72 (0.49) | 0.83 | 8.15 (1.98) | 10.00 (0.00) | < 0.001 | 1.85 (0.45); <0.001 |
CC prevention advocacy | 3.23 (1.13) | 3.57 (1.16) | 0.35 | 2.90 (1.10) | 4.98 (0.11) | < 0.001 | 1.94 (0.20); <0.001 |
Mean CC screening advocacy across alters | 1.96 (0.19) | 1.85 (0.51) | 0.39 | 2.03 (0.06) | 2.19 (0.21) | 0.004 | 0.16 (0.05); 0.003 |